Objective This study aimed to evaluate fetal epicardial fat thickness (EFT) along with fetal myocardial performance index (MPI) and its effects on perinatal outcomes in non‐severe idiopathic polyhydramnios (IP). Materials and Methods This prospective study included 92 participants, 32 diagnosed with non‐severe IP, and 60 healthy pregnant women. Amniotic fluid indices (AFI), umbilical and middle cerebral artery Doppler, EFT, and MPI measurements were performed for all patients. Results The fetal EFT and MPI values were statistically higher in the non‐severe IP group than in the control group (p = 0.0001, p = 0.014, respectively). The optimal fetal EFT cutoff value for predicting non‐severe IP disease was found as 1.3 mm with a specificity of 81.7% and sensitivity of 59.4%. The EFT cutoff for predicting cesarean section in non‐severe IP cases was 1.25 mm (p = 0.038). Apgar scores, neonatal intensive care unit, respiratory distress syndrome, and stillbirth rates were not different between groups. Conclusion In this study, EFT and MPI were found to be higher in non‐severe IP cases compared to controls. It was observed that the increase in MPI and EFT was associated with the increase in cesarean rates, but not with adverse fetal outcomes.
Objective: In this study, we aimed to investigate the role of peripheral blood parameters and the systemic inflammatory index (SII) in the diagnosis of hyperemesis gravidarum (HG) and whether they have a predictive value in determining the length of hospital stay and the risk of rehospitalization in HG cases. Materials and methods: In the retrospective study, pregnant women who were hospitalized due to HG (n = 112) and pregnant women who were completely healthy (n = 112) were matched for gestational age. Peripheral blood inflammation parameters of the entire study group were evaluated. The length of hospital stay and rehospitalization rate for HG cases were recorded. A total of 224 patients, 112 (50%) in the control group and 112 (50%) in the HG group were included in the study. There was a positive correlation between increased ketonuria and length of hospitalization, peripheric blood parameters, and SII. The degree of ketonuria was found to be statistically insignificant in determining the risk of rehospitalization (p = 0.927). About 28.57% (n = 32) of all HG cases were readmitted to the hospital. When the length of hospital stay was considered, SII was found to be statistically significant in hospitalizations lasting more than 2 days (p = 0.001), but not in rehospitalizations (p = 0.3). Conclusion: SII is significant in diagnosing and determining hospitalization of HG. It is sufficient to determine the length of hospital stay but not rehospitalization risk, which is an indicator of disease severity. Key words: hyperemesis gravidarum – hospitalization – inflammation markers – systemic inflammatory index
Purpose: This study aimed to investigate the surgical outcomes and safety of cesarean section myomectomies. Methods: This retrospective study was performed between January 2015 and August 2022, at a single university hospital. Pregnant women diagnosed with myoma uteri who underwent C/S (cesarean section) myomectomy and pregnant women without myoma as the control group and only underwent C/S were included in the study. Patients' age, gravida, parity, abortion, body mass index (BMI), delivery week, previous delivery type, myoma size, type, number, localization, preoperative and postoperative hemoglobin (Hb) values and postoperative Hb changes, operation time, hospital stay, blood transfusion need and amount, and postoperative complications were recorded from the hospital archive system. The obtained data were compared between the two groups. Results: A total of 283 patients underwent C/S myomectomy and 324 patients who did not have myoma underwent only C/S. Duration of operation, length of hospital stay, postoperative blood transfusion need and amount of blood transfusion, preoperative Hb, and change of Hb values were statistically significantly higher in the C/S myomectomy group (p<0.01, p<0.01, p=0.005, p= 0.006, p<0.01, p<0.01, respectively). A statistically significant weak positive correlation was observed between fibroid size and hospital stay (ρ=0.133). There was a statistically significant weak positive correlation between the size of myoma and the amount of blood transfused (ρ=0.120). Conclusion: Myomectomy during cesarean section has a low complication rate and saves patients from the necessity of a second operation.
Introduction Cesarean scar pregnancy (CSP) is an increasing clinical condition that causes serious maternal morbidity and mortality. This study aimed to evaluate if inflammation markers measured by hemogram can aid in the diagnosis of CSP. Materials and Methods A total of 86 patients were included in the study. The cases were divided as CSP (n: 42) and normal pregnancy (NP) (n: 44). At the time of admission, peripheral blood neutrophils, lymphocytes, monocytes, thrombocytes, systemic inflammatory index (SII) (neutrophil × platelet/lymphocyte), neutrophil–lymphocyte ratio, monocyte–lymphocyte ratio, and platelet–lymphocyte ratio were all measured. CSP and NP diagnoses were made by transabdominal or vaginal ultrasonography. Results In the CSP group, mean age (p < 0.001), gravida (p < 0.001), parity (p < 0.001), number of surviving children (p < 0.001), number of abortions (p < 0.001), cesarean number (p < .001), dilatation and curettage count (p = 0.013), monocyte (M) value (p = 0.039) and monocyte/lymphocyte value (MLR) (p = 0.035) were significantly higher than the control group. The optimal M value cut-off value was found to be > 0.40, the sensitivity value was 78.57, and the specificity value was 50.00. AUC = 0.632 (SE = 0.061) for the MLR value. The optimal MLR cut-off value was found to be > 0.232, the sensitivity value was 61.90, and the specificity value was 63.64. Conclusion Hemogram parameters, which are simple, inexpensive, and easily accessible, M and MLR are significantly higher in the diagnosis of CSP and can be used as an auxiliary parameter for ultrasonography.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.